The association between zinc and prostate cancer development: A systematic review and meta-analysis
PLOS ONE · 20.03.2024 · 19 (3) · e0299398
DOI: 10.1371/journal.pone.0299398 ↗Kurz gefasst
Metaanalyse in der Zeitschrift PLOS ONE, online erschienen am 20.03.2024. Verfasst von Shahrzad Shahrokhi Nejad und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Zinc. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Prostate cancer is affecting males globally, with several complications. Zinc can play roles in cancers. We aimed to clarify the association between zinc levels or intake with prostate cancer development.
Methods
We searched PubMed, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL), and Web of Science until May 1, 2023. We included case-controls and cross-sectionals that measured zinc level and/or intake in patients with prostate cancer or cohorts that evaluated the association between zinc and prostate cancer development. Studies that did not have a healthy control group were excluded. Joanna Briggs Institute was used for quality assessment. Publication bias was evaluated using Egger’s and Begg’s tests and funnel plot.
Results
Overall, 52 studies (n = 44 case controls, n = 4 cohorts, and n = 4 cross sectionals) with a total number of 163909 participants were included. Serum (standardized mean difference (SMD): -1.11; 95% confidence interval (CI): -1.67, -0.56), hair (SMD: -1.31; 95% CI: -2.19, -0.44), and prostatic fluid or tissue zinc levels (SMD: -3.70; 95% CI: -4.90, -2.49) were significantly lower in prostate cancer patients. There were no significant differences in nail zinc level and zinc intake between those with prostate cancer and healthy controls. There was no publication bias except for serum and hair zinc levels based on Begg’s and Egger’s tests, respectively. The mean risk of bias scores were 4.61 in case-controls, eight in cohorts, and seven in cross-sectionals.
Conclusions
Overall, high zinc levels might have a protective role in prostate cancer, which can be used as a therapeutic or preventive intervention. Future large-scale studies are needed to confirm the association.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Endocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran.
- Systematic Review and Meta-analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
- Evidence Based Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Shahrzad Shahrokhi Nejad, Seyed Aria Nejadghaderi
Zitieren
APA
Shahrokhi Nejad, S., Golzari, Z., Zangiabadian, M., Salehi Amniyeh Khozani, A. A., Ebrahimi, R., Nejadghaderi, S. A., & Aletaha, A. (2024). The association between zinc and prostate cancer development: A systematic review and meta-analysis. PLOS ONE, 19(3), e0299398. https://doi.org/10.1371/journal.pone.0299398
Vancouver
Shahrokhi Nejad S, Golzari Z, Zangiabadian M, Salehi Amniyeh Khozani AA, Ebrahimi R, Nejadghaderi SA, et al. The association between zinc and prostate cancer development: A systematic review and meta-analysis. PLOS ONE. 2024;19(3):e0299398. doi:10.1371/journal.pone.0299398
BibTeX
@article{ShahrokhiNejad2024,
author = {Shahrokhi Nejad, Shahrzad and Golzari, Zahra and Zangiabadian, Moein and Salehi Amniyeh Khozani, Amir Abbas and Ebrahimi, Rasoul and Nejadghaderi, Seyed Aria and Aletaha, Azadeh},
title = {The association between zinc and prostate cancer development: A systematic review and meta-analysis},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {3},
pages = {e0299398},
doi = {10.1371/journal.pone.0299398}
}
EUVIMED